Senates

Degree | Department/Program | Institute | Year |
GRADUATE | BIOLOGY | ANKARA UNIVERSITY | 2003 |
2006 | |||
2011 |
1. Investigation of Citalopram in point of Pharmacogenetic and Pharmacokinetic in Patients with Major Depression , Supervisor: Dr. Halit Sinan SÜZEN, Ankara University, Graduate School of Health Sciences, Pharmaceutical Toxicology Department, Ankara, Turkey, 2011.
https://tez.yok.gov.tr/UlusalTezMerkezi/">https://tez.yok.gov.tr/UlusalTezMerkezi/
1. Investigation on the genotoxic effects of boron exposure in humans , Supervisor: Dr. Yalçın - DUYDU, Ankara University, Graduate School of Health Sciences, Pharmaceutical Toxicology Department, Ankara, Turkey, 2006.
https://tez.yok.gov.tr/UlusalTezMerkezi/">https://tez.yok.gov.tr/UlusalTezMerkezi/
Title | Institute | Year |
ASST. ASSOC. DR. | MERSIN UNIVERSITY | 2013-02-27 - 2021-08-25 |
DOC. DR. | MERSIN UNIVERSITESI | 2021-08-25 - 2021-10-18 |
Title | Dutie | Institution/Other | Year |
FAKULTE KURULU UYESI | ECZACILIK FAKULTESI | MERSIN UNIVERSITESI | 2021-09-24 - 2024-09-24 |
DEKAN YARDIMCISI | ECZACILIK FAKULTESI | MERSIN UNIVERSITESI | 2020-07-13 - 2023-03-12 |
FAKULTE KURULU UYESI | PHARMACY FACULTY | MERSIN UNIVERSITY | 2016-10-04 - 2019-10-04 |
HEAD OF DEPARTMENT | PHARMACY FACULTY | MERSIN UNIVERSITY | 2013-09-23 - 2015-02-10 |
2022
16. UÇKUN ŞAHİNOĞULLARI, Z.; CANACANKATAN, N.; CANACANKATAN, M.; YALAZA, C. IMPACTS OF CYP7A1 AND SLCO1B1 POLYMORPHISMS ON SERUM LIPID LEVELS IN HEALTHY TURKISH POPULATION. ACTA MEDICA MEDITERRANEA, 2022, 38, 631-638. 0 + 010.19193/0393-6384_2022_1_99
2020
15. DEMİRBÜGEN ÖZ, M.; BASKAK, B.; UÇKUN, Z.; YÜCE ARTUN, N.; ÖZDEMİR, H.; ÖZEL KIZIL, T.; DEVRİMCİ ÖZGÜVEN, H.; SÜZEN, H. . PHARMACOGENOMICS JOURNAL, 2020, 20, 443-450. 550 + 010.1038/s41397-019-0127-8
14. GÜZEL, S.; UÇKUN ŞAHİNOĞULLARI, Z.; CANACANKATAN, N.; ANTMEN, Ş.; KİBAR, D.; COŞKUN YILMAZ, B. . DRUG AND CHEMICAL TOXICOLOGY, 2020, 43, 630-636. 0 + 010.1080/01480545.2019.1584208
13. UÇKUN, Z.; GÜZEL, S.; CANACANKATAN, N.; YALAZA, C.; KİBAR, D.; COŞKUN YILMAZ, B. . DRUG AND CHEMICAL TOXICOLOGY, 2020, 43, 104-111. 850 + 010.1080/01480545.2018.1512612
12. Guzel, S.; Uckun , Z.; Canacankatan, N.; Antmen, S.; Kibar, D.; Coskun Yilmaz, B. Potential renoprotective effects of silymarin against vancomycin-induced nephrotoxicity in rats. DRUG CHEM TOXICOL, 2020, 43, 630-636. 750 + 0http://dx.doi.org/10.1080/01480545.2019.1584208
11. UÇKUN, Z.; GÜZEL, S.; CANACANKATAN, N.; YALAZA, C.; KİBAR, D.; COŞKUN YILMAZ, B. . DRUG AND CHEMICAL TOXICOLOGY, 2020, 43, 104-111. 850 + 010.1080/01480545.2018.1512612
10. Uckun, Z.; Güzel, S.; Canacankatan, N.; Yalaza, C.; Kibar, D.; Coskun Yilmaz, B. Potential protective effects of naringenin against vancomycin-induced nephrotoxicity via reduction on apoptotic and oxidative stress markers in rats.. DRUG AND CHEMICAL TOXICOLOGY, 2020, 43, 104-111. 850 + 0doi: 10.1080/01480545.2018.1512612
9. Oz, M.; Baskak, B.; Uckun, Z.; Artun, N.; Ozdemir, H.; Ozel, T.; Ozguven, H.; Suzen, H. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients. PHARMACOGENOMICS J, 2020, 20, 443-450. 550 + 0http://dx.doi.org/10.1038/s41397-019-0127-8
2018
8. Demirbugen Oz, M.; Uckun, Z.; Yuce-Artun, N.; Baskak, B.; Ozdemir, H.; Kizil Ozel, T.; Devrimci Ozguven, H.; Suzen, H. The relationship between the serotonin 2A receptor gene -1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients. HUMAN PSYCHOPHARMACOLOGY, 2018, 33, ---. 650 + 0http://dx.doi.org/10.1002/hup.2673
7. DEMİRBÜGEN ÖZ, M.; UÇKUN, Z.; YÜCE ARTUN, N.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, T.; DEVRİMCİ ÖZGÜVEN, H.; SÜZEN, H. . HUMAN PSYCHOPHARMACOLOGY: CLINICAL AND EXPERIMENTAL, 2018, 33, -. 650 + 010.1002/hup.2673
2016
6. YÜCE ARTUN, N.; BASKAK, B.; ÖZEL KIZIL, E.; ÖZDEMİR, H.; UÇKUN, Z.; DEVRİMCİ ÖZGÜVEN, H.; SÜZEN, H. . INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38, 388-394. 400 + 010.1007/s11096-016-0259-8
5. Yuce-Artun, N.; Baskak, B.; Ozel-Kizil, E.; Ozdemir, H.; Uckun, Z.; Devrimci-Ozguven, H.; Suzen, H. Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38, 388-394. 400 + 0http://dx.doi.org/10.1007/s11096-016-0259-8
2015
4. Uckun, Z.; Baskak, B.; Ozel-Kizil, E.; Ozdemir, H.; Devrimci Ozguven, H.; Suzen, H. The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder . JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS., 2015, 40, 672-679. 850 + 0http://dx.doi.org/10.1111/jcpt.12320
3. UÇKUN, Z.; BASKAK, B.; ÖZEL KIZIL, E.; ÖZDEMİR, H.; DEVRİMCİ ÖZGÜVEN, H.; SÜZEN, H. . JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40, 672-679. 850 + 010.1111/jcpt.12320
2010
2. Suzen, H.; Gucyener, E.; Sakalli, O.; Uckun, Z.; Kose, G.; Ustel, D.; Duydu, Y. CAT C-262T and GPX1 Pro198Leu polymorphisms in a Turkish population. MOLECULAR BIOLOGY REPORTS, 2010, 37, 87-92. 500 + 60http://dx.doi.org/10.1007/s11033-009-9540-4
Times Cited: 12
1. SÜZEN, H.; GÜÇYENER, E.; SAKALLI, Ö.; UÇKUN, Z.; KÖSE, G.; ÜSTEL, D.; DUYDU, Y. . MOLECULAR BIOLOGY REPORTS, 2010, 37, 87-92. 500 + 010.1007/s11033-009-9540-4
2015
2. Uckun, Z.; Mcadam, L.; Suzen, H.; Jenkins, G. Investigation of the Association between the CYP7A1 A-203C Polymorphism and Barrett’s Esophagus in British Population. JOURNAL OF APPLIED BIOLOGICAL SCIENCES, 2015, 9, 69-71. 190 + 0
2012
1. Uckun, Z. Recent Studies on Pharmacokinetic of Citalopram and Therapeutic Drug Monitoring. NEW HORIZONS IN SCIENCE & TECHNOLOGY, 2012, 1, 27-32. 200 + 0
2015
2. UÇKUN, Z.; MCADAM, L.; SÜZEN, H.; JENKINS, G. . JOURNAL OF APPLIED BIOLOGICAL SCIENCES, 2015, 9, 69-71. 95 + 0
2013
1. UÇKUN, Z. . TURK BILIMSEL DERLEMELER DERGISI, 2013, 6, 119-123. 100 + 0
2021
22. UÇKUN ŞAHİNOĞULLARI, Z. . JOURNAL OF SURGERY AND MEDICINE, 2021, 5, 221-225. 0 + 010.28982/josam.871071
21. UÇKUN ŞAHİNOĞULLARI, Z. . JOURNAL OF CONTEMPORARY MEDICINE, 2021, 11, 208-214. 0 + 010.16899/jcm.836287
20. UÇKUN ŞAHİNOĞULLARI, Z. Frequencies of glutathione S-transferase A1 rs3957357 polymorphism in a Turkish population. JOURNAL OF SURGERY AND MEDICINE, 2021, 5, 221-225. 0 + 0http://dx.doi.org/10.28982/josam.871071
19. UÇKUN ŞAHİNOĞULLARI, Z. The Evaluation of Genetic Profiles of UGT1A4 and UGT1A6 in the Turkish Population. JOURNAL OF CONTEMPORARY MEDICINE, 2021, 11, 208-214. 0 + 0http://dx.doi.org/10.16899/jcm.836287
18. UÇKUN ŞAHİNOĞULLARI, Z.; GÜZEL, S.; CANACANKATAN, N.; YALAZA, C.; KİBAR, D.; BAYRAK, G. Hepatic Inflammation and Apoptosis Induced by Vancomycin in Rats and the Potential Protective Effects of Naringenin. CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, 2021, 11, 191-198. 0 + 0http://dx.doi.org/10.33808/clinexphealthsci.741916
17. UÇKUN ŞAHİNOĞULLARI, Z. . DICLE MEDICAL JOURNAL, 2021, 48, 72-82. 0 + 010.5798/dicletip.887418
16. UÇKUN ŞAHİNOĞULLARI, Z.; GÜZEL KARA, S.; CANACANKATAN, N.; YALAZA, C.; KİBAR, D.; BAYRAK, G. . CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, 2021, 11, 191-198. 0 + 010.33808/clinexphealthsci.741916
2020
15. UÇKUN ŞAHİNOĞULLARI, Z. . MEDICINE SCIENCE, 2020, 9, 314-319. 0 + 010.5455/medscience.2019.08.9189
14. UÇKUN ŞAHİNOĞULLARI, Z. Cytochrome P450 2A13 3375C>T gene polymorphism in a Turkish population. ISTANBUL JOURNAL OF PHARMACY, 2020, 50, 181-187. 0 + 0
13. UÇKUN ŞAHİNOĞULLARI, Z. . ISTANBUL JOURNAL OF PHARMACY, 2020, 50, 181-187. 0 + 010.26650/IstanbulJPharm.2020.0049
12. Sahinogullari, Z. Genetic polymorphism of CYP2C8 4 in a healthy Turkish population. MEDICINE SCIENCE, 2020, 9, 314-319. 0 + 010.5455/medscience.2019.08.9189
2019
11. Uckun, Z.; Canacankatan, N.; Canacankatan, M. Genotype and allele frequencies of SLCO1B1 g.89595 T>C polymorphism in a healthy Turkish population. JOURNAL OF RESEARCH IN PHARMACY, 2019, 23, 1149-1156. 100 + 0
10. UÇKUN ŞAHİNOĞULLARI, Z.; CANACANKATAN, N.; CANACANKATAN, M. . JOURNAL OF RESEARCH IN PHARMACY, 2019, 23, 1149-1156. 0 + 010.35333/jrp.2019.80
9. GÜZEL, S.; UÇKUN ŞAHİNOĞULLARI, Z.; CANACANKATAN, N.; ANTMEN, Ş.; KİBAR, D. The ameliorating effect of silymarin against vancomycin-induced apoptosis and inflammation in rat liver. JOURNAL OF RESEARCH IN PHARMACY , 2019, 23, 719-728. 0 + 0http://dx.doi.org/10.12991/jrp.2019.181
8. GÜZEL, S.; UÇKUN ŞAHİNOĞULLARI, Z.; CANACANKATAN, N.; ANTMEN, Ş.; KİBAR, D.; BAYRAK, G. . JOURNAL OF RESEARCH IN PHARMACY, 2019, 23, 719-728. 0 + 010.12991/jrp.2019.181
2018
7. Uçkun, Z.; Baskak, B.; Özdemir, H.; Özel-kızıl, E.; Devrimci-özgüven, H.; Süzen, S. Genotype and Allele Frequency of CYP3A4 -392A>G in Turkish patients with major depressive disorder. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 15, 200-206. 85 + 0http://dx.doi.org/10.4274/tjps.46320
6. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; DEVRİMCİ ÖZGÜVEN, H.; SÜZEN, H. . TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 15, 200-206. 85 + 010.4274/tjps.46320
2016
5. Uçkun , Z.; Başkak, B.; Özdemir, H.; Özel Kızıl, E.; Devrimci Özgüven, H.; Süzen, H. Association Between The 5-HTTLPR Polymorphism and Response to Citalopram in Turkish Patients With Major Depressive Disorder. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 13, 145-158. 85 + 0
4. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; DEVRİMCİ ÖZGÜVEN, H.; SÜZEN, H. . TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 13, 145-148. 85 + 010.5505/tjps.2016.29484
2009
3. UÇKUN, Z.; ÜSTÜNDAĞ, A.; KORKMAZ, M.; DUYDU, Y. . ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI, 2009, 38, 79-88. 95 + 010.1501/Eczfak_0000000518
2. Uckun, Z.; Suzen, S. Quantitative determination of citalopram and its metabolite desmethycitalopram in plasma by high performance liquid chromatography. FABAD JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 34, 195-201. 100 + 8
1. UÇKUN, Z.; SÜZEN, H. . FABAD JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 34, 195-201. 100 + 0
2012
1. UÇKUN, Z. . NEW HORIZONS IN SCIENCE & TECHNOLOGY, 2012, 1, 27-32. 100 + 0
2013
3. Uckun, Z. Esansiyel Bir Komponent: Bor -Borun Günlük Alımı ve Fizyolojik Etkileri-. TURK BILIMSEL DERLEMELER DERGISI, 2013, 6, 119-123. 100 + 0
2010
2. Süzen, H.; Uçkun, Z. Toxicity of Statins. MODERN FITOFARMAKOTERAPI VE DOGAL FARMASOTIKLER, 2010, 1, 14-21. 100 + 0
2009
1. Uckun, Z.; Üstündağ, A.; Korkmaz, M.; Duydu, Y. Micronucleus levels and sister chromatide exchange frequencies in boron exposed and control individuals. ANKARA ECZAZILIK FAKULTESI DERGISI, 2009, 38, 79-88. 95 + 0
2010
1. SÜZEN, H.; UÇKUN, Z. . MODERN FITOFARMAKOTERAPI VE DOGAL FARMASOTIKLER, 2010, 1, 14-21. 100 + 0
1. UÇKUN, Z. Casarett & Doull’s Toksikolojinin Temelleri, ISBN: 978-605-9215-18-3, Ankara Nobel Tıp Yayınevi, Number of print: 1, Total Printing Number: , 540 Page, Turkish, Ankara, Turkey, 2017. 0
2. Uçkun, Z. Casarett&Doull's Toksikolojinin Temelleri, ISBN: 978-6059215-18-3, Ankara Nobel Tıp Kitabevleri, Number of print: 3, Total Printing Number: 100, 11 Page, Turkish, Ankara, Turkey, 2017. 50
1. UÇKUN , Z. Toksikoloji Terimleri Karşılıklar Kılavuzu, ISBN: 978-605-80196-1-4, Yüksek İhtisas Üniversitesi, Number of print: 1, Total Printing Number: , 125 Page, Turkish, Ankara, Turkey, 2020. 0
2. AKTAY, G.; YAKINCI, C.; AYDIN, A.; ÇELİK, A.; LERMİOĞLU ERCİYAS, F.; YURDUN, T.; YALÇIN AZARKAN, S.; BABA, B.; BARAN, A.; UÇKUN ŞAHİNOĞULLARI, Z. Toksikoloji Terimleri Karşılıklar Kılavuzu, ISBN: 978-605-80196-1-4, Yüksek İhtisas Üniversitesi, Number of print: 1, Total Printing Number: 300, 113 Page, Turkish, Ankara, Turkey, 2020. 45
14. UÇKUN ŞAHİNOĞULLARI, Z., UDP-glucuronosyltransferase 1A8 rs1042597 polymorphism in a Turkish population. 6th International Hippocrates Congress on Medical and Health Sciences, 2021-04-30, 2021-05-01, Ankara, Turkey, 2021. 0
13. UÇKUN ŞAHİNOĞULLARI, Z., Genetic analysis of SLC22A1 rs628031 and rs72552763 gene polymorphisms in a Turkish population and their inter-population comparisons. 6th International Medicine and Health Sciences Researches Congress, 2021-04-10, 2021-04-11, Ankara, Turkey, 2021. 0
12. UÇKUN ŞAHİNOĞULLARI, Z., Genetic analysis of SLC22A1 rs628031 and rs72552763 gene polymorphisms in a Turkish population and their inter-population comparisons. 6th International Medicine and Health Sciences Researches Congress (UTSAK), 2021-04-10, 2021-04-11, Ankara, Turkey, . 0
11. UÇKUN, Z.; KİBAR, D.; GÜZEL, S.; BAYRAK, G., HISTOPATHOLOGICAL EFFECTS OF SILYMARIN IN THE LIVER TISSUES OF VANCOMYCIN-ADMINISTERED RATS. . 12th International Symposium on Pharmaceutical Sciences (ISOPS), 2018-06-26, 2018-06-29, Ankara, Turkey, 2018. 95
10. DEMİRBÜGEN, M.; UÇKUN, Z.; YÜCE ARTUN, N.; DEVRİMCİ ÖZGÜVEN, H.; SÜZEN, H., THE 5-HYDROXYTRIPTAMINE 2A RECEPTOR -1438A/G AND 102T/C POLIMORPHISMS AND NAUSEA SIDE EFFECT IN CITALOPRAM TREATED MAJOR DEPRESSIVE DISORDER PATIENTS. 12th International Symposium on Pharmaceutical Sciences (ISOPS), 2018-06-26, 2018-06-29, Ankara, Turkey, 2018. 80
Scientific_Meetings_008.pdf
9. UÇKUN, Z.; KİBAR, D.; GÜZEL, S.; BAYRAK, G., Histopathological effects of silymarin in the liver tissues of vancomycin-administered rats. 12th International Symposium on Pharmaceutical Sciences (ISOPS-12), 2018-06-26, 2018-06-29, Ankara, Turkey, . 95
8. DEMİRBÜGEN, M.; UÇKUN, Z.; YÜCE ARTUN, N.; DEVRİMCİ ÖZGÜVEN, H.; SÜZEN, H., The 5-hydroxytriptamine 2a receptor -1438A/G and 102T/C polimorphisms and nausea side effect in citalopram treated major depressive disorder patients. 12th International Symposium on Pharmaceutical Sciences (ISOPS-12), 2018-06-26, 2018-06-29, Ankara, Turkey, . 80
7. DEMİRBÜGEN, M.; UÇKUN, Z.; YÜCE ARTUN, N.; SÜZEN, S., The serotonin 2A receptor gene -1438A/G polymorphism and sertraline induced nausea in major depressed Turkish patients. 2nd International Gazi Pharma Symposiu Series - GPSS 2017, 2017-10-11, 2017-10-13, Ankara, Turkey, . 85
6. UÇKUN, Z.; KİBAR, K.; GÜZEL, S.; COŞKUN YILMAZ, B., Histopathological examination of the effects of silymarin on vancomycin-induced nephrotoxicity in rats. 2nd International Gazi Pharma Symposiu Series - GPSS 2017, 2017-10-11, 2017-10-13, Ankara, Turkey, . 95
5. UÇKUN, Z.; KİBAR, K.; GÜZEL, S.; COŞKUN YILMAZ, B., HISTOPATHOLOGICAL EXAMINATION OF THE EFFECTS OF SILYMARIN ON VANCOMYCIN-INDUCED NEPHROTOXICITY IN RATS. 2nd International Gazi Pharma Symposium Series , 2017-10-11, 2017-10-13, Ankara, Turkey, 2017. 95
Scientific_Meetings_005.pdf
4. DEMİRBÜGEN, M.; UÇKUN, Z.; YÜCE ARTUN, N.; SÜZEN, S., THE SEROTONIN 2A RECEPTOR GENE -1438A/G POLYMORPHISM AND SERTRALINE INDUCED NAUSEA IN MAJOR DEPRESSED TURKISH PATIENTS. 2nd International Gazi Pharma Symposium Series , 2017-10-11, 2017-10-13, Ankara, Turkey, 2017. 85
Scientific_Meetings_006.pdf
3. KİBAR, K.; UÇKUN, Z.; GÜZEL, S.; COŞKUN YILMAZ, B., Histopathological Effects of Naringenin on Vancomycin-induced Nephrotoxicity in Rats. 3 rd International Multidisciplinary Symposium on Drug Research and Development - DRD 2017, 2017-10-05, 2017-10-07, Erzurum, Turkey, 2017. 85
Scientific_Meetings_001.pdf
2. KİBAR, K.; UÇKUN, Z.; GÜZEL, S.; COŞKUN YILMAZ, B., Histopathological effects of naringenin on vancomycin-induced nephrotoxicity in rats. 3rd International Multidisciplinary Symposium on Drug Research and Development - DRD 2017, 2017-10-05, 2017-10-07, Erzurum, Turkey, . 85
1. Süzen, H.; Uçkun, Z.; Yüce Artun, N., Translation of Pharmacogenetics to Clinical Practice. International Symposium on Drug Research & Development, 2015-10-15, 2015-10-17, Eskişehir, Turkey, 2015. 100
35. UÇKUN ŞAHİNOĞULLARI, Z.; CANACANKATAN, N.; CANACANKATAN, M.; YALAZA, C., Genetic polymorphism of CYP7A1 and serum total cholesterol levels in a healthy Turkish population. International Hippocrates Congress on Medical and Health Sciences, 2019-03-01, 2019-03-03, Ankara, Turkey, 2019. 0
34. UÇKUN ŞAHİNOĞULLARI, Z.; CANACANKATAN, N.; CANACANKATAN, M.; YALAZA, C., Genetic polymorphism of CYP7A1 and serum total cholesterol levels in a healthy Turkish population. International Hippocrates Congress on Medical and Health Sciences, 2019-03-01, 2019-03-03, Ankara, Turkey, . 0
33. GÜZEL, S.; UÇKUN, Z.; CANACANKATAN, N.; ANTMEN, E.; YALAZA, C.; KİBAR, K.; COŞKUN YILMAZ, B., Investigation of effects of naringenin on vancomycin-induced nephrotoxicity in rats. 2nd International Gazi Pharma Symposiu Series - GPSS 2017, 2017-10-11, 2017-10-13, Ankara, Turkey, . 35
32. GÜZEL, S.; UÇKUN, Z.; CANACANKATAN, N.; ANTMEN, E.; YALAZA, C.; KİBAR, K.; COŞKUN YILMAZ, B., INVESTIGATION OF EFFECTS OF NARINGENIN ON VANCOMYCIN-INDUCED NEPHROTOXICITY IN RATS. 2nd International Gazi Pharma Symposium Series , 2017-10-11, 2017-10-13, Ankara, Turkey, 2017. 35
Scientific_Meetings_007.pdf
31. UÇKUN, Z.; SÜZEN, S., THE POTENTIAL ROLE OF CYP2D6PHARMACOGENETICS ON CODEINE TOXICITY. 2nd International Congress of Forensic Toxicology, 2016-05-26, 2016-05-30, Ankara, Turkey, 2016. 50
http://forensictoxicologycongress.com/wp-content/uploads/2016/06/Abstract-book_50.-y%C4%B1l-Auditorium.pdf
30. DEMİRBÜGEN, M.; UÇKUN, Z.; YÜCE, N.; BASKAK, B.; SÜZEN, H., 5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment. TurkHeltox Toxicology Congress; 9th Congress of the Turkish Society of Toxicology with the participation of the Hellenic Society of Toxicology, 2015-10-21, 2015-10-24, İzmir, Turkey, . 40
29. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, H., The relationship between BDNF Val66Met polymorphism and side effects in major depression patients treated with citalopram. International Multidisciplinary Symposium on Drug Research & Development - DRD 2015, 2015-10-15, 2015-10-17, Eskişehir, Turkey, . 42
28. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, S., The relationship between 5-HTTLPR polymorphism and side effects in major depression patients treated with citalopram. International Multidisciplinary Symposium on Drug Research & Development - DRD 2015, 2015-10-15, 2015-10-17, Eskişehir, Turkey, . 42
27. Uçkun, Z.; Başkak, B.; Özdemir, H.; Özel Kızıl, E.; Özgüven, H.; Süzen, S., The Relationship Between 5-HTTLPR Polymorphism and Side Effects in Major Depression Patients Treated with Citalopram. International Symposium on Drug Research & Development, 2015-10-15, 2015-10-17, Eskişehir, Turkey, 2015. 42
26. Uçkun, Z.; Başkak, B.; Özdemir, H.; Özel Kızıl , E.; Özgüven , H.; Süzen, S., The Relationship Between BDNF Val66Met Polymorphism and Side Effects in Major Depression Patients Treated with Citalopram. International Symposium on Drug Research & Development, 2015-10-15, 2015-10-17, Eskişehir, Turkey, 2015. 42
25. Uçkun, Z.; Başkak, B.; Özdemir, H.; Özel Kızıl , E.; Özgüven , H.; Süzen, H., CYP2C19*17 Polymorphism and Major Depression Patients Treated With Citalopram. 11th International Symposium on Pharmaceutical Sciences, 2015-06-09, 2015-06-12, Ankara, Turkey, 2015. 42
24. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, H., CYP2C19*17 polymorphism and major depression patients treated with citalopram. 11th International Symposium on Pharmaceutical Sciences (ISOPS-11), 2015-06-09, 2015-06-12, Ankara, Turkey, . 42
23. UÇKUN, Z.; SÜZEN, S., The potential role of CYP2D6 pharmacogenetics in forensic toxicology. 1st International Congress and Workshop of Forensic Toxicology, 2014-11-29, 2014-11-30, Ankara, Turkey, . 50
22. Uçkun, Z.; Süzen, S., The Potential Role of CYP2D6 Pharmacogenetics on Forensic Toxicology. 1st International Congress and Workshop of Forensic Toxicology, 2014-11-29, 2014-11-30, Ankara, Turkey, 2014. 50
21. UÇKUN, Z.; ÖZDEMİR, H.; BASKAK, B.; ÖZEL KIZIL, E.; DEVRİMCİ ÖZGÜVEN, H.; SÜZEN, S., 5 HTTLPR&BDNF Val66Met polymorphisms and major depression patients treated with citalopram. 4th International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-4), 2014-09-18, 2014-09-21, İstanbul, Turkey, . 42
20. UÇKUN, Z., The relationship between CYP2C9 pharmacogenetics and dose-related ADRs. 4th International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-4), 2014-09-18, 2014-09-21, İstanbul, Turkey, . 50
19. Uçkun, Z.; Özdemir , H.; Başkak, B.; Özel Kızıl , E.; Özgüven , H.; Süzen, S., 5-HTTLPR&BDNF Val66Met Polymorphisms and Major Depression Patients Treated With Citalopram. 4th International Meeting on Pharmacy & Pharmaceutical Sciences, 2014-09-18, 2014-09-21, İstanbul, Turkey, 2014. 42
18. Uçkun, Z., The Relationship Between CYP2C9 Pharmacogenetics and Dose-Related ADRs. 4th International Meeting on Pharmacy & Pharmaceutical Sciences, 2014-09-18, 2014-09-21, İstanbul, Turkey, 2014. 50
17. Süzen, H.; Yüce, N.; Uçkun, Z., Quantitation of Sertraline and Its Metabolite by HPLC in Plasma. 4th EuCheMS Chemistry Congress, 2012-08-26, 2012-08-26, Prag, Czech Republic, 2012. 50
16. Uçkun, Z.; Başkak, B.; Özdemir, H.; Özel Kızıl , E.; Özgüven , H.; Süzen, S., Influence of Serotonin Transporter Promoter Region Polymorphism on Psychic Side Effects in Major Depression Patients Treated with Citalopram. 10th Internetional Symposium on Pharmaceutical Sciences, 2012-06-26, 2012-06-29, Ankara, Turkey, 2012. 42
15. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, S., Assessment of sexual dysfunction symptoms in citalopram- treated major depression patients. 10th International Symposium on Pharmaceutical Sciences (ISOPS-10), 2012-06-26, 2012-06-29, Ankara, Turkey, . 42
14. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, S., Effect of BDNF polymorhism on psychic side effects in citalopram- treated major depression patients. 10th International Symposium on Pharmaceutical Sciences (ISOPS-10), 2012-06-26, 2012-06-29, Ankara, Turkey, . 42
13. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, S., Influence of serotonin transporter promoter region polymorphism on psychic side effects in major depression patients treated with citalopram. 10th International Symposium on Pharmaceutical Sciences (ISOPS-10), 2012-06-26, 2012-06-29, Ankara, Turkey, . 42
12. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, S., Role of brain-derived neurotrophic factor Val66Met polymorphism on treatment response in major depression patients treated with citalopram. 10th International Symposium on Pharmaceutical Sciences (ISOPS-10), 2012-06-26, 2012-06-29, Ankara, Turkey, . 42
11. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, S., Influence of 5-HTTLPR polymorphism on treatment response in major depression patients treated with citalopram. 10th International Symposium on Pharmaceutical Sciences (ISOPS-10), 2012-06-26, 2012-06-29, Ankara, Turkey, . 42
10. Uçkun, Z.; Başkak, B.; Özdemir, H.; Özel Kızıl , E.; Özgüven , H.; Süzen, S., Role of Brain-Derived Neurotrophic Factor Val66Met Polymorphism on Treatment Response in Major Depression Patients Treated with Citalopram. 10th Internetional Symposium on Pharmaceutical Sciences, 2012-06-26, 2012-06-29, Ankara, Turkey, 2012. 42
9. Uçkun, Z.; Başkak, B.; Özdemir, H.; Özel Kızıl , E.; Özgüven , H.; Süzen, S., Influence of 5-HTTLPR Polymorphism on treatment response in major depression patients treated with citalopram. 10th Internetional Symposium on Pharmaceutical Sciences, 2012-06-26, 2012-06-29, Ankara, Turkey, 2012. 42
8. Uçkun, Z.; Başkak, B.; Özdemir, H.; Özel Kızıl , E.; Özgüven , H.; Süzen, S., Assessment of Sexual Dysfunction Symptoms in Citalopram-Treated Major Depression Patients. 10th Internetional Symposium on Pharmaceutical Sciences, 2012-06-26, 2012-06-29, Ankara, Turkey, 2012. 42
7. Uçkun, Z.; Başkak, B.; Özdemir, H.; Özel Kızıl , E.; Özgüven , H.; Süzen, S., Effect of BDNF Polymorhism on Psychic Side Effects in Citalopram -Treated Major Depression Patients. 10th Internetional Symposium on Pharmaceutical Sciences, 2012-06-26, 2012-06-29, Ankara, Turkey, 2012. 42
6. UÇKUN, Z.; BASKAK, B.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, H., The role of CYP2C19 polymorphism in major depression patients treated with citalopram. 14th Biennial Meeting of the European Behavioural Pharmacology Society, 2011-08-26, 2011-08-29, Amsterdam, Netherlands, . 45
5. Uçkun, Z.; Başkak, B.; Özel Kızıl, E.; Özguven, H.; Süzen, S., The Role of CYP2C19 Polymorphism in Major Depression Patients Treated with Citalopram. 14th Biennial Meeting of the European Behavioural Pharmacology Society, 2011-08-26, 2011-08-29, Amsterdam, Netherlands, 2011. 45
4. Duydu, Y.; Uçkun, Z.; Üstündağ, A.; Ündeğer, Ü.; Aydın, S.; Korkmaz, M.; Başaran, N., Assessment of genotoxicity in environmentally boron exposure by using alkaline COMET and CBMN assay. 10th International Conference on Environmental Mutagens, 2009-08-20, 2009-08-25, Firenze, Italy, 2009. 35
3. DUYDU, Y.; UÇKUN, Z.; ÜSTÜNDAĞ, A.; ÜNDEĞER, Ü.; AYDIN, S.; KORKMAZ, M.; BAŞARAN, N., Assessment of genotoxicity in environmentally boron exposure by using alkaline COMET and CBMN assay. 10th International Conference on Environmental Mutagens, 2009-08-20, 2009-08-25, Firenze, Italy, . 35
2. UÇKUN, Z.; MCADAM, L.; SÜZEN, H.; JENKINS, G., Cholesterol 7α-hydrolase (CYP7A1) -203 A>C promoter polymorphism in barrett’s oesophagus. 9th International Symposium on Pharmaceutical Sciences (ISOPS-9), 2009-06-23, 2009-06-26, Ankara, Turkey, . 47
1. Uçkun, Z.; Mcadam, L.; Süzen, H.; Jenkins, G., Cholesterol 7α-Hydrolase (Cyp7a1) -203 A>C Promoter Polymorphism in Barrett’s Oesophagus. 9th Internetional Symposium on Pharmaceutical Sciences, 2009-06-23, 2009-06-26, Ankara, Turkey, 2009. 47
2. SÜZEN, H.; UÇKUN, Z.; YÜCE ARTUN, N.; BASKAK, B.; ÖZEL KIZIL, E.; ÖZDEMİR, H.; DEVRİMCİ ÖZGÜVEN, H., The impact of genetic differences on SSRIs metabolism in depressed patients. TurkHeltox Toxicology Congress; 9th Congress of the Turkish Society of Toxicology with the participation of the Hellenic Society of Toxicology, 2015-10-21, 2015-10-24, İzmir, Turkey, . 0
1. SÜZEN, H.; UÇKUN, Z.; YÜCE ARTUN, N., Translation of Pharmacogenetics to Clinical Practice. International Multidisciplinary Symposium on Drug Research & Development - DRD 2015, 2015-10-15, 2015-10-17, Eskişehir, Turkey, . 0
4. SÜZEN, H.; UÇKUN, Z.; DEVRİMCİ ÖZGÜVEN, H., Plazma Sitalopram ve Metaboliti Desmetilsitalopramın Majör Depresif Hastalarda HPLC ile Tayini. 17. Kromatografi Kongresi, 2017-09-20, 2017-09-22, Çorum, Turkey, 2017. 50
http://kromatografi-17.hitit.edu.tr/
3. UÇKUN, Z.; GÜZEL, S.; KİBAR, K.; COŞKUN YILMAZ, B., Sıçanlara günde bir kez ve günde iki kez uygulanan vankomisinin nefrotoksisitesindeki farklılılar. 1. Anadolu Üniversitesi Eczacılık Sempozyumu (AnES), 2017-06-01, 2017-06-02, Eskişehir, Turkey, . 47
2. UÇKUN, Z.; GÜZEL, S.; KİBAR, K.; COŞKUN YILMAZ, B., Sıçanlara günde bir kez ve günde iki kez uygulanan Vankomisinin nefrotoksisitesindeki farklılılar. 1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu , 2017-06-01, 2017-06-02, Eskişehir, Turkey, 2017. 47
http://anes.anadolu.edu.tr/upload/anes2017_kitapcik.pdf
1. Süzen, H.; Uçkun, Z.; Nazan, Y.; Baskak, B.; Özel Kızıl, E.; Özdemir, H.; Devrimci Özgüven, H., The impact of genetic differences on SSRIs metabolism in depressed patients. TurkHeltox Toxicology Congress, 2015-10-21, 2015-10-24, İzmir, Turkey, 2015. 35
15. Uçkun, Z.; TÜRKMENDAĞ, E., Genotoksisite Testleri. 1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu, 2017-06-01, 2017-06-02, Eskişehir, Turkey, 2017. 25
http://anes.anadolu.edu.tr/upload/anes2017_kitapcik.pdf
14. UÇKUN, Z.; TÜRKMENDAĞ, E., Genotoksisite testleri. 1. Anadolu Üniversitesi Eczacılık Sempozyumu (AnES), 2017-06-01, 2017-06-02, , Turkey, . 25
13. Demirbügen, M.; Uçkun, Z.; Yüce, N.; Baskak, B.; Suzen, H., 5-HT2A receptor 102T/C polymorphism and incidence of nausea induced by sertraline treatment. TurkHeltox Toxicology Congress; 9th Congress of the Turkish Society of Toxicology with the participation of the Hellenic Society of Toxicology, 2015-10-21, 2015-10-24, İzmir, Turkey, 2015. 20
12. UÇKUN, Z.; TEKİN, N., CYP2D6 genetik polimorfizmin advers ilaç reaksiyonların oluşumundaki etkisi. Türk Toksikoloji Derneği III. Bölgesel Toksikoloji Sempozyumu, 2014-06-12, 2014-06-14, İzmir, Turkey, . 25
11. Uçkun, Z.; Tekin, N., CYP2D6 Genetik Polimorfizmin Advers İlaç Reaksiyonların Oluşumundaki Etkisi. Türk Toksikoloji Derneği, III. Bölgesel Toksikoloji Sempozyumu, 2014-06-12, 2014-06-14, İzmir, Turkey, 2014. 25
10. Uçkun, Z.; Başkak, B.; Özdemir, H.; Özel Kızıl , E.; Özgüven , H.; Süzen, S., Sitalopram ile Tedavi Olan Major Depresyon Hastalarında CYP2C19*17 Polimorfizmin Etkisinin Araştırılması. Türk Toksikoloji Derneği, II. Bölgesel Toksikoloji Sempozyumu, 2013-05-03, 2013-05-05, Eskişehir, Turkey, 2013. 21
9. UÇKUN, Z.; BASKAK, B.; ÖZDEMİR, H.; ÖZEL KIZIL, E.; ÖZGÜVEN, H.; SÜZEN, H., Sitalopram ile tedavi olan major depresyon hastalarında CYP2C19*17 polimorfizmin etkisinin araştırılması. Türk Toksikoloji Derneği, II. Bölgesel Toksikoloji Sempozyumu, 2013-05-03, 2013-05-04, Eskişehir, Turkey, . 21
8. UÇKUN, Z.; SÜZEN, S., Plazmada sitalopram (SİT) ve desmetilsitalopramın (DSİT) yüksek performanslı sıvı kromatografisi (YBSK) ile tayini. Çevre ve Toksikoloji Sempozyumu, 2010-10-22, 2010-10-22, Mersin, Turkey, . 25
7. Uçkun, Z.; Süzen, S., Plazmada Sitalopram (SİT) ve Desmetilsitalopramın (DSİT) Yüksek Performanslı Sıvı Kromatografisi (YPSK) ile tayini. Çevre ve Toksikoloji Sempozyumu, 2010-10-22, 2010-10-22, Mersin, Turkey, 2010. 25
6. Uçkun, Z.; Süzen, H.; Mcadam, L.; Jenkins, G., Kolesterol 7α- Hydrolase (CYP7A1) Genin Promoter Bölgesindeki -203 A>C Polimorfizmin Barrett Özofaguslu Hastalarda Araştırılması. XI. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 2009-10-28, 2009-10-31, Bodrum, Turkey, 2009. 23
5. UÇKUN, Z.; SÜZEN, H.; MCADAM, L.; JENKINS, G., Kolesterol 7α- hidrolaz (CYP7A1) genin promoter bölgesindeki -203 A>C polimorfizmin barrett özofaguslu hastalarda araştırılması. XI. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 2009-10-28, 2009-10-31, Bodrum, Turkey, . 23
4. SÜZEN, H.; GÜÇYENER, E.; SAKALLI, Ö.; UÇKUN, Z.; KÖSE, G.; ÜSTEL, D.; DUYDU, Y., CAT C-262T ve GPX1 Pro198Leu polimorfizmlerinin Türk populasyonunda araştırılması. 7. Uluslararası Katılımlı Türk Toksikoloji Derneği Kongresi, 2009-05-30, 2009-06-01, Ankara, Turkey, . 12
3. Süzen, H.; Güçyener, E.; Sakallı, Ö.; Uçkun, Z.; Köse, G.; Üstel, D.; Duydu, Y., CAT C-262T ve GPX1 Pro198Leu Polimorfizmlerinin Türk Populasyonunda Araştırılması. 7. Uluslararası Katılımlı Türk Toksikoloji Derneği Kongresi, 2009-05-30, 2009-06-01, Ankara, Turkey, 2009. 12
2. KORKMAZ, M.; ÇEBİ, A.; UÇKUN, Z.; DUR, A.; DUYDU, Y., Bor maruziyetinin insanlar üzerindeki genotoksik etkilerinin araştırılması. X. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 2007-09-06, 2007-09-09, Antalya, Turkey, . 17
1. Korkmaz, M.; ÇEBİ, A.; Uçkun, Z.; Dur, A.; Duydu, Y., Bor Maruziyetinin İnsanlar Üzerindeki Genotoksik Etkilerinin Araştırılması. X. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 2007-09-06, 2007-09-09, Antalya, Turkey, 2007. 17
1. SÜZEN, H.; UÇKUN, Z.; ÖZGÜVEN, H., Plazma sitalopram ve metaboliti desmetilsitalopramın majör depresif hastalarda HPLC ile tayini. 17. Kromatografi Kongresi, 2017-09-20, 2017-09-22, Çorum, Turkey, . 0
2. , BAP, Project Number: , 19985 TL, Manager, 2018,Completed. 100
1. CYP7A1 and SLCO gene polymorphisms and Investigation of Serum Lipid Profile in Healthy Individuals, BAP, Project Number: 2015-AP3-1367, 26995 TL, Manager, 2018,Completed. 100
2. INVESTIGATION OF THE EFFECTS OF SILYMARIN AND NARINGENIN ON THE TOXIC EFFECTS OF VANCOMYCIN ON VITAL ORGANS , BAP, Project Number: 2016-2-AP3-1906, 22312 TL, Researcher, 2018,Completed. 50
1. , BAP, Project Number: , 14999 TL, Researcher, 2017,Completed. 50
1. Antidepresan Tedavide CYP2C19, CYP3A4, SLC6A4 ve BDNF Genlerindeki Polimorfizmlerin ve Plazma Ilaç Düzeylerinin Sitalopram ve Sertralin Yanıtı ve Yan Etkiler Üzerine Etkisi, TÜBİTAK, Project Number: 109S147, 105000 TL, Scholarship, 2013,Completed. 0
11. Burcu YOLDAŞ, Gebelikte İlaç Kullanımının Toksikolojik Açıdan Değerlendirilmesi, Graduate School of Health Sciences, Mersin University, Completed. 0
10. Nevcihan TEKİN, Advers İlaç Reaksiyonları ve Sitokrom P4502D6 Genetik Polimorfizmi, Graduate School of Health Sciences, Mersin University, Completed. 0
9. Engin TÜRKMENDAĞ, Genotoksisite Testleri, Others, Mersin University, Completed. 0
8. Merve OCAK, Sitokrom P4502C19 Genetik Polimofizmi ve Toksikolojik Açıdan Önemi, Graduate School of Health Sciences, Mersin University, Completed. 0
7. Yunus ORAN, Psikiyatrik Hastalıklarda Farmakogenetik Çalışmaların Önemi, Graduate School of Health Sciences, Mersin University, Completed. 0
6. İskan MAFRAK, Serbest Radikalleri ve Reaktif Oksijen Türlerinin Toksikolojideki Önemi, Graduate School of Health Sciences, Mersin University, Completed. 0
5. Vedat FIRAT, Kurşun Toksisitesi, Graduate School of Health Sciences, Mersin University, Completed. 0
4. Ali CAĞLİ, Civa Toksisitesi, Graduate School of Health Sciences, Mersin University, Completed. 0
3. Ersel ÜSTE, Yaşlılıkta İlaç Kullanımının Toksikolojik Açıdan Değerlendirilmesi, Graduate School of Health Sciences, Mersin University, Completed. 0
2. Maruf POLAT, Antikanser İlaçların Toksikolojik Açıdan İncelenmesi, Graduate School of Health Sciences, Mersin University, Completed. 0
1. Mahmut SOBAY, Gıda Katkı Maddeleri ve Kontaminantların Toksikolojik Açıdan Değerlendirilmesi, Graduate School of Health Sciences, Mersin University, Completed. 0
1. DRUG AND CHEMICAL TOXICOLOGY , [ 2019 : 1 ] . 5
2. FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , [ 2019 : 1 ] . 0
3. HUMAN AND EXPERIMENTAL TOXICOLOGY , [ 2018 : 5 ] [ 2019 : 2 ] [ 2020 : 2 ] [ 2021 : 1 ] . 50
4. JOURNAL OF CONTEMPORARY MEDICINE , [ 2019 : 1 ] . 4
5. MEDICINE SCIENCE | INTERNATIONAL MEDICAL JOURNAL , [ 2017 : 4 ] [ 2018 : 1 ] [ 2019 : 2 ] . 28
6. TOXICOLOGY RESEARCH , [ 2020 : 1 ] . 4
1. TURKISH BULLETIN OF HYGIENE AND EXPERIMENTAL BIOLOGY , [ 2018 : 1 ] . 1